Orion Portfolio Solutions’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$264K Buy
+2,266
New +$258K ﹤0.01% 1683
2024
Q4
– Sell
-2,751
Closed -$247K – 1826
2024
Q3
$247K Sell
2,751
-53
-2% -$4.63K ﹤0.01% 1615
2024
Q2
$226K Sell
2,804
-179
-6% -$13.3K ﹤0.01% 1581
2024
Q1
$238K Buy
2,983
+60
+2% +$5.04K ﹤0.01% 1550
2023
Q4
$260K Sell
2,923
-440
-13% -$29.4K ﹤0.01% 1467
2023
Q3
$235K Buy
3,363
+19
+0.6% +$1.42K ﹤0.01% 1488
2023
Q2
$240K Buy
+3,344
New +$247K ﹤0.01% 1493

Other funds holding AXSM

Orion Portfolio Solutions's AXSM Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in Axsome Therapeutics (AXSM) in Q1 2025: 2,266 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #1683 among its holdings. This is a return to the name: Orion Portfolio Solutions previously reported a position in AXSM as recently as Q3 2024.

Orion Portfolio Solutions first reported a position in AXSM in Q2 2023 and has held it in 7 quarters since. 353 funds tracked by Wall St. Rank hold AXSM as of Q1 2025.

  • Orion Portfolio Solutions held 2,266 shares of Axsome Therapeutics worth $264K as of Q1 2025.
  • Axsome Therapeutics was a new Orion Portfolio Solutions position in Q1 2025.
  • Axsome Therapeutics made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1683 holding.
  • Orion Portfolio Solutions first reported a position in Axsome Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • 353 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.